Emiri T Mandeville, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Brain Ischemia | 11 | 2023 | 3258 | 1.270 |
Why?
|
Stroke | 16 | 2024 | 9963 | 1.040 |
Why?
|
Brain Edema | 3 | 2022 | 617 | 0.670 |
Why?
|
Infarction, Middle Cerebral Artery | 6 | 2022 | 475 | 0.530 |
Why?
|
Blood-Brain Barrier | 4 | 2023 | 1015 | 0.480 |
Why?
|
Brain | 18 | 2023 | 26343 | 0.410 |
Why?
|
Neural Stem Cells | 5 | 2018 | 847 | 0.410 |
Why?
|
Neurogenesis | 5 | 2018 | 829 | 0.350 |
Why?
|
Cerebrovascular Circulation | 5 | 2024 | 2732 | 0.350 |
Why?
|
A Kinase Anchor Proteins | 2 | 2020 | 51 | 0.340 |
Why?
|
Oligodendroglia | 3 | 2018 | 514 | 0.310 |
Why?
|
Neuroprotective Agents | 3 | 2019 | 941 | 0.270 |
Why?
|
Brain Infarction | 2 | 2019 | 296 | 0.270 |
Why?
|
Diffusion Magnetic Resonance Imaging | 4 | 2018 | 2736 | 0.250 |
Why?
|
Hypercapnia | 2 | 2023 | 260 | 0.240 |
Why?
|
Ischemic Attack, Transient | 2 | 2022 | 934 | 0.240 |
Why?
|
Cerebral Hemorrhage | 4 | 2019 | 2643 | 0.220 |
Why?
|
Rats | 20 | 2023 | 24265 | 0.220 |
Why?
|
Microelectrodes | 1 | 2023 | 303 | 0.210 |
Why?
|
Circadian Rhythm | 2 | 2024 | 2623 | 0.190 |
Why?
|
Animals | 41 | 2024 | 168561 | 0.190 |
Why?
|
Recovery of Function | 4 | 2020 | 2924 | 0.190 |
Why?
|
Sphingosine | 1 | 2022 | 307 | 0.180 |
Why?
|
Endothelium, Lymphatic | 1 | 2019 | 58 | 0.180 |
Why?
|
Antipyrine | 2 | 2016 | 40 | 0.170 |
Why?
|
Vascular Endothelial Growth Factor C | 1 | 2019 | 126 | 0.170 |
Why?
|
Mice, Inbred C57BL | 12 | 2022 | 21821 | 0.170 |
Why?
|
Oxygen Inhalation Therapy | 2 | 2013 | 363 | 0.170 |
Why?
|
Vascular Endothelial Growth Factor Receptor-3 | 1 | 2019 | 118 | 0.170 |
Why?
|
Disease Models, Animal | 10 | 2024 | 18006 | 0.170 |
Why?
|
Rats, Wistar | 7 | 2018 | 1902 | 0.170 |
Why?
|
Microglia | 2 | 2020 | 1261 | 0.170 |
Why?
|
Biological Transport | 1 | 2023 | 2119 | 0.170 |
Why?
|
Electrodes, Implanted | 1 | 2023 | 824 | 0.160 |
Why?
|
Blood Volume Determination | 1 | 2018 | 43 | 0.160 |
Why?
|
Free Radical Scavengers | 2 | 2016 | 217 | 0.160 |
Why?
|
Cell Cycle Proteins | 2 | 2020 | 3444 | 0.150 |
Why?
|
Astrocytes | 2 | 2016 | 1266 | 0.150 |
Why?
|
Oxygen | 4 | 2014 | 4169 | 0.150 |
Why?
|
Cerebral Cortex | 6 | 2023 | 5705 | 0.140 |
Why?
|
Tissue Plasminogen Activator | 2 | 2013 | 1262 | 0.140 |
Why?
|
C-Reactive Protein | 2 | 2020 | 3766 | 0.140 |
Why?
|
Ferrosoferric Oxide | 1 | 2018 | 360 | 0.140 |
Why?
|
Epidermal Growth Factor | 1 | 2019 | 709 | 0.140 |
Why?
|
Image Interpretation, Computer-Assisted | 4 | 2018 | 3328 | 0.140 |
Why?
|
Serum Amyloid P-Component | 1 | 2016 | 47 | 0.140 |
Why?
|
Endothelium | 1 | 2018 | 778 | 0.130 |
Why?
|
Endothelial Cells | 3 | 2023 | 3455 | 0.130 |
Why?
|
Spin Labels | 2 | 2018 | 332 | 0.120 |
Why?
|
Mice | 17 | 2024 | 81045 | 0.120 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2016 | 2552 | 0.120 |
Why?
|
Annexin A2 | 1 | 2013 | 44 | 0.120 |
Why?
|
Pericytes | 1 | 2016 | 291 | 0.120 |
Why?
|
Hemodynamics | 1 | 2024 | 4197 | 0.120 |
Why?
|
Isoquinolines | 1 | 2015 | 368 | 0.120 |
Why?
|
Amides | 1 | 2016 | 458 | 0.110 |
Why?
|
Lipocalins | 1 | 2014 | 170 | 0.110 |
Why?
|
Carbon Monoxide | 1 | 2016 | 531 | 0.110 |
Why?
|
Microscopy, Fluorescence, Multiphoton | 1 | 2015 | 271 | 0.110 |
Why?
|
Acute-Phase Proteins | 1 | 2014 | 262 | 0.110 |
Why?
|
Lipoxygenase Inhibitors | 1 | 2012 | 94 | 0.110 |
Why?
|
Organometallic Compounds | 1 | 2016 | 665 | 0.110 |
Why?
|
Brain Chemistry | 1 | 2016 | 981 | 0.110 |
Why?
|
Rats, Sprague-Dawley | 7 | 2019 | 8300 | 0.110 |
Why?
|
Arachidonate 15-Lipoxygenase | 1 | 2012 | 85 | 0.110 |
Why?
|
Arachidonate 12-Lipoxygenase | 1 | 2012 | 80 | 0.110 |
Why?
|
Inflammation Mediators | 1 | 2021 | 1889 | 0.100 |
Why?
|
Intracranial Embolism | 1 | 2013 | 202 | 0.100 |
Why?
|
Myofibrils | 1 | 2012 | 146 | 0.100 |
Why?
|
Echo-Planar Imaging | 2 | 2018 | 659 | 0.100 |
Why?
|
Oxygen Consumption | 2 | 2015 | 1869 | 0.100 |
Why?
|
Antifibrinolytic Agents | 1 | 2013 | 254 | 0.100 |
Why?
|
Microscopy | 2 | 2014 | 903 | 0.100 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2013 | 689 | 0.090 |
Why?
|
Hemorrhage | 1 | 2022 | 3461 | 0.090 |
Why?
|
Tomography, Optical Coherence | 2 | 2013 | 2637 | 0.090 |
Why?
|
Isoflurane | 1 | 2013 | 381 | 0.090 |
Why?
|
Nerve Tissue Proteins | 2 | 2020 | 4465 | 0.090 |
Why?
|
Pattern Recognition, Automated | 1 | 2016 | 996 | 0.090 |
Why?
|
Radio Waves | 1 | 2011 | 251 | 0.090 |
Why?
|
Dendrites | 1 | 2012 | 485 | 0.090 |
Why?
|
Protons | 2 | 2016 | 1126 | 0.090 |
Why?
|
Models, Cardiovascular | 1 | 2015 | 994 | 0.090 |
Why?
|
Structure-Activity Relationship | 1 | 2015 | 3133 | 0.090 |
Why?
|
Pyrazines | 1 | 2015 | 1231 | 0.080 |
Why?
|
Luminescent Measurements | 1 | 2011 | 405 | 0.080 |
Why?
|
Cerebral Infarction | 3 | 2022 | 1007 | 0.080 |
Why?
|
Blood Pressure | 1 | 2024 | 8541 | 0.080 |
Why?
|
Lymph Nodes | 1 | 2019 | 3465 | 0.080 |
Why?
|
Magnetic Resonance Angiography | 1 | 2015 | 1440 | 0.080 |
Why?
|
Drug Delivery Systems | 1 | 2019 | 2217 | 0.080 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2013 | 960 | 0.080 |
Why?
|
Male | 25 | 2022 | 349538 | 0.070 |
Why?
|
Diabetes Complications | 1 | 2013 | 1359 | 0.070 |
Why?
|
Rats, Inbred SHR | 2 | 2016 | 195 | 0.070 |
Why?
|
Neovascularization, Pathologic | 1 | 2016 | 2633 | 0.070 |
Why?
|
Brain Mapping | 2 | 2023 | 6669 | 0.070 |
Why?
|
Cell Differentiation | 3 | 2018 | 11470 | 0.070 |
Why?
|
Image Enhancement | 2 | 2016 | 2921 | 0.070 |
Why?
|
Culture Media, Conditioned | 2 | 2018 | 533 | 0.070 |
Why?
|
Mitochondria | 1 | 2018 | 3520 | 0.060 |
Why?
|
Acute Disease | 4 | 2018 | 7141 | 0.060 |
Why?
|
Vascular Diseases | 1 | 2013 | 1155 | 0.060 |
Why?
|
Macrophages | 1 | 2019 | 5655 | 0.060 |
Why?
|
Aging | 3 | 2023 | 8626 | 0.060 |
Why?
|
Diffusion Tensor Imaging | 1 | 2014 | 2304 | 0.060 |
Why?
|
Myocytes, Cardiac | 1 | 2012 | 1636 | 0.060 |
Why?
|
Magnetic Resonance Imaging | 4 | 2023 | 35342 | 0.060 |
Why?
|
Alzheimer Disease | 1 | 2024 | 7988 | 0.050 |
Why?
|
Oxidative Stress | 1 | 2013 | 3081 | 0.050 |
Why?
|
Matrix Metalloproteinase 9 | 2 | 2016 | 638 | 0.050 |
Why?
|
Cells, Cultured | 4 | 2020 | 19223 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 1 | 2014 | 4553 | 0.050 |
Why?
|
Cytokines | 1 | 2016 | 7317 | 0.050 |
Why?
|
Neurons | 3 | 2016 | 9325 | 0.050 |
Why?
|
Nanoparticles | 1 | 2012 | 1902 | 0.050 |
Why?
|
Capillaries | 2 | 2014 | 774 | 0.050 |
Why?
|
Partial Pressure | 2 | 2011 | 253 | 0.050 |
Why?
|
Positron-Emission Tomography | 1 | 2016 | 6259 | 0.050 |
Why?
|
Myocardium | 1 | 2012 | 4775 | 0.040 |
Why?
|
rho-Associated Kinases | 1 | 2020 | 279 | 0.040 |
Why?
|
Corpus Callosum | 1 | 2024 | 737 | 0.040 |
Why?
|
Humans | 11 | 2024 | 742088 | 0.040 |
Why?
|
Cell Membrane Permeability | 1 | 2020 | 590 | 0.040 |
Why?
|
Microcirculation | 1 | 2023 | 1285 | 0.040 |
Why?
|
Algorithms | 3 | 2016 | 13853 | 0.040 |
Why?
|
Lymphangiogenesis | 1 | 2019 | 172 | 0.040 |
Why?
|
Cell Proliferation | 3 | 2019 | 10472 | 0.040 |
Why?
|
Gelatin | 1 | 2019 | 225 | 0.040 |
Why?
|
Reactive Oxygen Species | 2 | 2016 | 2077 | 0.040 |
Why?
|
Mice, Transgenic | 2 | 2024 | 9735 | 0.040 |
Why?
|
Disease Progression | 1 | 2013 | 13256 | 0.040 |
Why?
|
Immunity | 1 | 2022 | 1011 | 0.030 |
Why?
|
Spleen | 1 | 2022 | 2359 | 0.030 |
Why?
|
Bromodeoxyuridine | 1 | 2016 | 322 | 0.030 |
Why?
|
Nitric Oxide Synthase Type I | 1 | 2016 | 170 | 0.030 |
Why?
|
Models, Animal | 2 | 2014 | 2170 | 0.030 |
Why?
|
Endothelium, Vascular | 2 | 2020 | 4455 | 0.030 |
Why?
|
Neck | 1 | 2019 | 693 | 0.030 |
Why?
|
Maze Learning | 1 | 2016 | 478 | 0.030 |
Why?
|
Half-Life | 1 | 2015 | 658 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2020 | 14554 | 0.030 |
Why?
|
Hydrogels | 1 | 2019 | 723 | 0.030 |
Why?
|
Arterioles | 1 | 2014 | 253 | 0.030 |
Why?
|
Myelin Sheath | 1 | 2018 | 652 | 0.030 |
Why?
|
Synaptophysin | 1 | 2013 | 141 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2016 | 3502 | 0.030 |
Why?
|
Ischemia | 1 | 2022 | 1911 | 0.030 |
Why?
|
Nitric Oxide Synthase | 1 | 2016 | 916 | 0.030 |
Why?
|
Anions | 1 | 2012 | 133 | 0.030 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2016 | 627 | 0.030 |
Why?
|
Crosses, Genetic | 1 | 2013 | 791 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2015 | 10943 | 0.030 |
Why?
|
Middle Cerebral Artery | 1 | 2013 | 264 | 0.030 |
Why?
|
Immunohistochemistry | 2 | 2016 | 11363 | 0.020 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2013 | 472 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2020 | 3504 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2016 | 14720 | 0.020 |
Why?
|
Solubility | 1 | 2012 | 1083 | 0.020 |
Why?
|
Interleukin-1beta | 1 | 2016 | 972 | 0.020 |
Why?
|
Porphyrins | 1 | 2012 | 348 | 0.020 |
Why?
|
Models, Chemical | 1 | 2012 | 626 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2014 | 1589 | 0.020 |
Why?
|
Cell Death | 1 | 2016 | 1695 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2016 | 2372 | 0.020 |
Why?
|
Phenotype | 2 | 2020 | 16331 | 0.020 |
Why?
|
Regional Blood Flow | 1 | 2013 | 1525 | 0.020 |
Why?
|
Endovascular Procedures | 1 | 2023 | 1973 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2015 | 1372 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2013 | 11695 | 0.020 |
Why?
|
Blood Volume | 1 | 2011 | 565 | 0.020 |
Why?
|
Treatment Outcome | 5 | 2013 | 62966 | 0.020 |
Why?
|
Materials Testing | 1 | 2012 | 865 | 0.020 |
Why?
|
Probability | 1 | 2014 | 2502 | 0.020 |
Why?
|
Blotting, Western | 1 | 2016 | 5180 | 0.020 |
Why?
|
Anesthetics, Inhalation | 1 | 2013 | 571 | 0.020 |
Why?
|
Behavior, Animal | 1 | 2016 | 1882 | 0.020 |
Why?
|
Inflammation | 2 | 2019 | 10578 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2016 | 19862 | 0.020 |
Why?
|
Cerebral Angiography | 1 | 2013 | 1285 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2024 | 9410 | 0.020 |
Why?
|
Administration, Oral | 1 | 2015 | 3913 | 0.020 |
Why?
|
Up-Regulation | 1 | 2016 | 4211 | 0.020 |
Why?
|
Drug Discovery | 1 | 2015 | 1057 | 0.020 |
Why?
|
Fluorescent Dyes | 1 | 2015 | 1915 | 0.020 |
Why?
|
Nanotechnology | 1 | 2012 | 709 | 0.020 |
Why?
|
Biosensing Techniques | 1 | 2012 | 668 | 0.020 |
Why?
|
Neovascularization, Physiologic | 1 | 2013 | 1350 | 0.020 |
Why?
|
Cognition | 1 | 2023 | 6722 | 0.020 |
Why?
|
Neuronal Plasticity | 1 | 2014 | 1418 | 0.020 |
Why?
|
Ligands | 1 | 2012 | 3293 | 0.020 |
Why?
|
Polymers | 1 | 2012 | 1618 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2021 | 7901 | 0.020 |
Why?
|
Water | 1 | 2011 | 1388 | 0.020 |
Why?
|
Nitric Oxide | 1 | 2013 | 2128 | 0.020 |
Why?
|
Biocompatible Materials | 1 | 2012 | 1731 | 0.010 |
Why?
|
Embolization, Therapeutic | 1 | 2013 | 1392 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2013 | 6483 | 0.010 |
Why?
|
Nervous System Diseases | 1 | 2013 | 1617 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2010 | 2699 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2014 | 3584 | 0.010 |
Why?
|
Phosphorylation | 1 | 2013 | 8436 | 0.010 |
Why?
|
Models, Statistical | 1 | 2016 | 5100 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2013 | 8621 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2016 | 5851 | 0.010 |
Why?
|
Peptides | 1 | 2012 | 4392 | 0.010 |
Why?
|
Models, Molecular | 1 | 2010 | 5454 | 0.010 |
Why?
|
Models, Biological | 1 | 2016 | 9581 | 0.010 |
Why?
|
Aged | 3 | 2020 | 162944 | 0.010 |
Why?
|
Contrast Media | 1 | 2012 | 5295 | 0.010 |
Why?
|
Ultrasonography | 1 | 2012 | 5978 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2016 | 9639 | 0.010 |
Why?
|
Computer Simulation | 1 | 2011 | 6191 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2020 | 57683 | 0.010 |
Why?
|
Signal Transduction | 1 | 2018 | 23387 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2013 | 21719 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2011 | 8925 | 0.010 |
Why?
|
Female | 3 | 2020 | 379592 | 0.010 |
Why?
|
Time Factors | 1 | 2011 | 40054 | 0.010 |
Why?
|
Mutation | 1 | 2013 | 29717 | 0.010 |
Why?
|
Middle Aged | 1 | 2012 | 213127 | 0.000 |
Why?
|